Teva Pharmaceutical Industries Ltd (TEVA) Insider Ownership

Historic Insider Ownership Trends

Data spanning the past 90 days through February 07, 2026 reveals that Teva Pharmaceutical Industries's three principal insider shareholders consist of Director Amir Elstein (2.10Mn shares), President And Ceo Kare Schultz (1.54Mn shares), Director Roberto Mignone (472.92K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Amir Elstein 2,103,963 09 Jun, 2025
Kare Schultz President And Ceo 1,542,471 02 Nov, 2022
Roberto Mignone 472,915 09 Jun, 2025
Sol J Barer 426,272 09 Jun, 2025
Eliyahu Sharon Kalif Evp And Chief Financial Officer 403,288 16 Jun, 2025
Richard D Francis President And Ceo 271,783 06 Mar, 2025
Sven Dethlefs Evp And North America Commercial 165,381 08 Mar, 2023
Eric Drape Executive Vp Global Operations 145,915 07 Mar, 2024
Gerald M Lieberman 115,657 09 Jun, 2025
Rosemary A Crane 113,247 09 Jun, 2025
Perry Nisen 105,315 09 Jun, 2025
Ronit Satchi-Fainaro 97,909 09 Jun, 2025
Dov Bergwerk Acting Chief Legal Officer 96,983 01 Mar, 2024
Janet S. Vergis 73,697 09 Jun, 2025
Jean Michel Halfon 63,707 16 Jun, 2022
Christine Fox Evp And Head Of U.S. Commercial 63,647 24 Nov, 2025
Tal Zvi Zaks 58,772 09 Jun, 2025
Nechemia Jacob Peres 58,765 16 Jun, 2022
Eli Shani Evp Andglobal Marketing&Portfolio 54,228 07 Mar, 2023
Mark Sabag See "Remarks" 52,828 11 Dec, 2025
Richard Daniell Exec. Vp And European Commercial 48,384 11 Dec, 2025
Galia Inbar See "Remarks" 46,011 07 Mar, 2023
Varda Shalev 22,504 09 Jun, 2025
David R. Mcavoy Evp And Chief Legal Officer 13,027 09 Sep, 2025
Matthew Shields Evp And Global Operations 9,989 05 Jun, 2025
Angus Grant Evp And Business Development 8,848 13 Aug, 2024
Placid Jover See "Remarks" 6,774 05 Aug, 2025
Amir Weiss Chief Accounting Officer 5,650 18 Dec, 2025
Chen Lichtenstein 4,804 04 Dec, 2025
David Matthew Stark Exec. Vp Chief Legal Officer 2,974 08 Mar, 2023
Hafrun Fridriksdottir Executive Vp And Global R&D 1,387 19 May, 2022

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
16 Dec, 2025 Roberto Mignone Ordinary Shares D 77,400 $30.24 367,600 I S
16 Dec, 2025 Amir Weiss Ordinary Shares D 12,300 $30.20 5,650 D S
09 Dec, 2025 Mark Sabag Ordinary Shares A 118,724 $18.61 269,720 D M
09 Dec, 2025 Mark Sabag Ordinary Shares D 98,168 $28.70 52,828 D S
09 Dec, 2025 Mark Sabag Ordinary Shares D 118,724 $28.75 150,996 D S
09 Dec, 2025 Richard Daniell Ordinary Shares A 100,457 $18.61 148,841 D M
09 Dec, 2025 Richard Daniell Ordinary Shares A 15,011 $16.99 163,852 D M
09 Dec, 2025 Richard Daniell Ordinary Shares D 115,468 $28.68 48,384 D S
02 Dec, 2025 Chen Lichtenstein Ordinary Shares A 4,804 - 4,804 D M
26 Nov, 2025 Roberto Mignone Ordinary Shares D 50,000 $26.03 445,000 I S
20 Nov, 2025 Christine Fox Ordinary Shares D 28,229 $24.78 63,647 D S
20 Nov, 2025 Christine Fox Ordinary Shares A 63,492 - 91,876 D M
14 Nov, 2025 Christine Fox Ordinary Shares D 30,000 $25.11 28,384 D S
06 Nov, 2025 Roberto Mignone Ordinary Shares D 200,000 $24.11 495,000 I S
06 Nov, 2025 Amir Weiss Ordinary Shares D 12,300 $24.44 17,950 D S
05 Sep, 2025 David R. Mcavoy - - 13,027 D
05 Sep, 2025 David R. Mcavoy Ordinary Shares A 1,113 $18.86 13,027 D P
01 Aug, 2025 Eric A Hughes - - 0 D
01 Aug, 2025 Eric A Hughes Ordinary Shares A 52,742 - 52,742 D M
01 Aug, 2025 Eric A Hughes - - 52,742 D